Role of antithrombotic agents in heart failure. - Wikidata - wikimedia - TriplyDB

Role of antithrombotic agents in heart failure.

Role of antithrombotic agents in heart failure.

http://www.wikidata.org/entity/Q37998952

about

Medical management of stable coronary atherosclerosis.Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.Chronic exercise leads to antiaggregant, antioxidant and anti-inflammatory effects in heart failure patients.

P2860

Q38083007-86A191CF-6A83-4AA4-B6E6-DD93C84DB69B Q38164671-B8331F41-3D7E-4EB4-84FE-C7FB7EACC137 Q39414645-0325B1CF-D01D-4565-9F6B-F526325B2E89

P2860

Role of antithrombotic agents in heart failure.

http://www.wikidata.org/entity/Q37998952

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Role of antithrombotic agents in heart failure.

@en

Role of antithrombotic agents in heart failure.

@nl

type

label

Role of antithrombotic agents in heart failure.

@en

Role of antithrombotic agents in heart failure.

@nl

prefLabel

Role of antithrombotic agents in heart failure.

@en

Role of antithrombotic agents in heart failure.

@nl

P1433

Q37998952-E7A8F326-9464-4494-AF84-E91E49E5E35C

P1476

Q37998952-7EED83E6-7AE9-4D99-ACC8-9FC59DDBBB9C

P2093

Q37998952-1D16EA80-07B6-44E3-8C14-9504CAE41234

Q37998952-95081208-D20B-4BC6-8526-7D5D15B6943A

P2860

Q37998952-00B586F0-2395-4BA8-AA95-11A94C34017F

Q37998952-0C7FECEB-BB08-4D7B-B27C-ADFC080E8E78

Q37998952-11B06E2E-6916-4ECD-8DAF-A04BFF7384B5

Q37998952-180E594F-637B-459A-AC0A-0A4AB2043E29

Q37998952-21DEA50F-72BD-40E1-8A64-9E20596C8D04

Q37998952-2CF2BA8F-91F2-41D0-8E1A-9807F8BE57B8

Q37998952-309CD263-0DFC-446C-91E6-12593E6E9416

Q37998952-32B4C553-BA6F-41CF-AF12-2D5A3D158E9D

Q37998952-362D1DA9-3955-4639-82AF-397A20697B69

Q37998952-392FF233-C494-4CC3-80DB-E6009934A6FC

P2888

Q37998952-1D32197D-15D0-4306-8195-D637B27B8864

P304

Q37998952-98016A4E-BC5F-4F58-A901-36C3EAB96BA9

P31

Q37998952-A9163EF5-C4A8-4566-A907-9C4397AD8046

P356

Q37998952-3EE81969-738C-41CB-8145-94D87AE2174F

P433

Q37998952-290C8832-AC53-4AB2-877E-826110B2C8D9

P478

Q37998952-4499C126-C885-4DFC-BA54-056586329F8A

P50

Q37998952-975B5DFF-BBFC-468C-A525-D3795A4BF241

P577

Q37998952-22EAEEC0-607D-4A77-8E5A-45D5B72837AB

P698

Q37998952-962D5FA8-06FA-44BE-80C4-DC13B8670CDB

P921

Q37998952-31954D42-67F5-4C99-B16F-2FE300A25AEC

P356

S11886-012-0266-X

P1433

Current cardiology reports

P1476

Role of antithrombotic agents in heart failure

@en

P2093

Luca Cecchini

http://www.w3.org/2001/XMLSchema#string

Saqib Mumtaz

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure

Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers

Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure

Antithrombotic treatment and the incidence of angina pectoris

P2888

s11886-012-0266-x

P304

314-325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-012-0266-X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22467260

http://www.w3.org/2001/XMLSchema#string

P921